SecBot SecBot
8-K ·Filed Apr 20, 2026

SCYX

SCYNEXIS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001178253-26-000009
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor the company's upcoming proxy filing for the 2026 annual meeting to see if a replacement is named and for any changes in committee composition. No immediate financial impact is expected from this routine board transition.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$8.48
T+0 close · Apr 20, 2026 · via day close
Latest settled
−47.17%
T+60 · $4.48
Vs SPY
−54.07%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 21 $8.48entry
  2. T+1 · 7mo ago −2.83%α −3.84% · $8.24
  3. T+5 · 7mo ago −6.98%α −8.06% · $7.89
  4. T+20 · 6mo ago −38.02%α −42.23% · $5.26
  5. T+60 · 4mo ago −47.17%α −54.07% · $4.48
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Steven C. Gilman, a board member of SCYNEXIS Inc., notified the company of his intent to retire and not stand for re-election at the 2026 annual meeting. His departure is due to retirement and not related to any disagreement with the company.

Key Facts

  • Dr. Steven C. Gilman is retiring from the Board of Directors and will not stand for re-election at the 2026 annual meeting.
  • His term ends upon the conclusion of the 2026 Annual Meeting; he will remain Chair of the Compensation Committee and a member of the Nominating and Corporate Governance Committee until then.
  • The company stated the resignation was not due to any disagreement with management, operations, or strategy.

Financial Impact

No direct financial impact disclosed.

Risk Factors

  • Potential loss of institutional knowledge given Dr. Gilman's roles as Chair of the Compensation Committee and member of the Nominating and Corporate Governance Committee.
  • Governance continuity risk if replacements for key committee roles are not promptly disclosed.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001178253-26-000009
Document: 0001178253-26-000009-index-headers.html0001178253-26-000009
Document: 0001178253-26-000009-index.html0001178253-26-000009
Document: 0001178253-26-000009.txt0001178253-26-000009

Track record

15 reports on SCYX

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +33.49% at T+20 after the May 11, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 5/10 Entry $2.91 Now $2.91 −0.00% settles Nov 24
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $2.91 Now $2.91 +0.00% settles Nov 24
  3. Nov 5, 202611d ago S-3 Neutral 3/10 Entry $3.30 to $3.33 Now $2.91 −11.82% ▲ +0.91% −2.38% vs SPY
  4. Nov 5, 202611d ago Press Release Neutral 4/10 Entry $3.30 to $3.33 Now $2.91 −11.82% ▲ +0.91% −2.38% vs SPY
  5. Oct 22, 202625d ago Press Release Bullish 7/10 Entry $3.81 to $3.86 Now $2.91 −23.62% ▲ +1.31% +0.61% vs SPY
  6. Oct 6, 20265w ago Press Release Neutral 4/10 Entry $4.84 to $3.99 Now $2.91 −39.88% ▼ −17.56% −17.42% vs SPY
  7. Sep 28, 20267w ago Press Release Bullish 6/10 Entry $4.62 to $5.03 Now $2.91 −37.01% ▲ +8.87% +7.67% vs SPY
  8. Sep 22, 20267w ago 8-K Neutral 2/10 Entry $4.86 to $4.66 Now $2.91 −40.12% ▼ −4.12% −2.93% vs SPY
  9. Sep 10, 20269w ago 8-K Neutral 2/10 Entry $4.70 to $4.45 Now $2.91 −38.09% ▼ −5.32% −4.82% vs SPY
  10. Jun 26, 202620w ago 8-K Neutral 3/10 Entry $3.87 to $4.73 Now $2.91 −24.81% ▲ +22.22% +20.83% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 6h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026